De novo acute myeloid leukemia in adults younger than 60 years of age: Socioeconomic aspects and treatment results in a Brazilian university center

References

• Lowenberg B, Downing J R, Burnett A. Acute myeloid leukemia. N Engl J Med 1999; 341: 1051–1062
   PubMed Web of Science ®Google Scholar
• Mayer R J, Davis R B, Schiffer C A, Berg D T, Powell B L, Schulman P, et al. Intensive postremission chemotherapy in adults with acute myeloid leukemia. N Engl J Med 1994; 331: 896–903
   PubMed Web of Science ®Google Scholar
• Zittoun R A, Mandelli F, Willemze R, De Witte T, Labar B, Resegotti L, et al. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. N Engl J Med 1995; 332: 217–223
   PubMed Web of Science ®Google Scholar
• Harousseau J L, Cahn J Y, Pigno B, Witz F, Milpied N, Delain M, et al. Comparison of autologous bone marrow transplantation and intensive chemotherapy as postremission therapy in adult acute myeloid leukemia. Blood 1997; 90: 2978–2986
   PubMed Web of Science ®Google Scholar
• Cassileth P A, Harrington D P, Appelbaum F R, Lazarus H M, Rowe J M, Paietta E, et al. Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission. N Engl J Med 1998; 339: 1649–1656
   PubMed Web of Science ®Google Scholar
• Burnett A K, Goldstone A H, Stevens R MF, Hann I M, Rees J K, Gray R G, Wheatley K, for the UK Medical Research Council Adult and Children's Leukaemia Working Parties. Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of RMC AML 10 trial. Lancet 1998; 351: 700–708
   PubMed Web of Science ®Google Scholar
• Büchner T, Hiddemann W, Wörmann B, Löffler H, Gassmann W, Haferlach T, et al. Double induction strategy for acute myeloid leukemia: the effect of high-dose cytarabine with mitoxantrone instead of standard-dose cytarabine with daunorubicin and 6-thioguanine: a randomized trial by the German AML Cooperative Group. Blood 1999; 93: 4116–4124
   PubMed Web of Science ®Google Scholar
• Mengis C, Aebi S, Tobler A, Dahler W, Fey M F. Assessment of differences in patient populations selected or excluded from participation in clinical phase III acute myelogenous leukemia trials. J Clin Oncol 2003; 21: 3933–3939
   PubMed Web of Science ®Google Scholar
• Pulcheri W, Spector N, Nucci M, Morais J CO, Pimenta G, Oliveira H P. The treatment of acute myeloid leukemia in Brazil: progress and obstacles. Haematologica 1995; 80: 130–135
   PubMed Web of Science ®Google Scholar
• Fagundes E M, Rocha V G, Azevedo W M, Clementino N CD, Quintão J S, Ferraz M HC, Viana M B. Leucemia mielóide aguda do adulto: análise retrospectiva de 99 casos. Rev Bras Hematol Hemoter 1995; 7: 33–39
   Google Scholar
• Pagnano K BB, Traina F, Takahashi T, Oliveira G B, Rossini M S, Lorand-Metze I, et al. Conventional chemotherapy for acute myeloid leukemia: a Brazilian experience. São Paulo Med J 2000; 118: 173–178
   PubMedGoogle Scholar
• Bittencourt R, Fogliato L, Daudt L, Bittencourt H NS, Friederich J R, Fernandes F, et al. Leucemia mielóide aguda: perfil de duas décadas do Serviço de Hematologia do Hospital das Clínicas de Porto Alegre – RS. Rev Bras Hematol Hemoter 2003; 25: 15–22
   Google Scholar
• Lobato-Mendizabal E, Ruiz-Arguelles G J, Gomez-Almaguer D, Ganci-Cerrud G, Lozano De La Vega A, Labardini-Mendez J. Long-term treatment and prognostic factors in adult acute myeloblastic leukemia. Experience of the INNSZ group Puebla-Monterrey-Mexico. Rev Invest Clin 1991; 43: 215–222
   PubMed Web of Science ®Google Scholar
• Kakepoto G N, Burney I A, Zaki S, Adil S N, Khurshid M. Long-term outcomes of acute myeloid leukemia in adults in Pakistan. J Pak Med Assoc 2002; 52: 482–486
   PubMedGoogle Scholar
• Viana M A, Fernandes R AF, Oliveira B M, Murao M, Paes C A, Duarte A A. Nutritional and socio-economic status in the prognosis of childhood acute lymphoblastic leukemia. Haematologica 2001; 86: 113–120
   PubMed Web of Science ®Google Scholar
• Viana M B, Murao M, Ramos G, Oliveira H M, De Carvalho R I, De Bastos M, et al. Malnutrition as a prognostic factor in lymphoblastic leukaemia: a multivariate analysis. Arch Dis Child 1994; 71: 304–310
   PubMed Web of Science ®Google Scholar
• Viana M B, Fernandes R A, De Carvalho R I, Murao M. Low socioeconomic status is a strong independent predictor of relapse in childhood acute lymphoblastic leukemia. Int J Cancer 1998; 11: 56–61
   Web of Science ®Google Scholar
• Paes C A, Viana M B, Freire R V, Martins-Filho O A, Taboada D C, Rocha V G. Direct association of socio-economic status with T-cell acute lymphoblastic leukaemia in children. Leuk Res 2003; 27: 789–794
   PubMed Web of Science ®Google Scholar
• IBGE (Instituto Brasileiro de Estatística), (cited 27 March 2004). Available from: http://www.ibge.gov.br
   Google Scholar
• Human Development Reports, (cited 27 March 2004). Available from URL: http://www.undp.org/hdr2003/
   Google Scholar
• Human Development Reports, (cited 27 March 2004). Available from URL: http://www.pnud.org.br/index
   Google Scholar
• Bennett J M, Catovsky D, Daniel M T, Flandrin G, Galton D AG, Gralnick H R, Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia: a report of the French – American – British Cooperative Group. Ann Intern Med 1985; 103: 626–629
   PubMedGoogle Scholar
• Grimwade D, Walker H, Harrison G, Oliver F, Chatters S, Harrison C J, et al. The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML 11 trial. Blood 2001; 98: 1312–1320
   PubMed Web of Science ®Google Scholar
• Fenaux P, Le Deley M C, Castaigne S, Archimbaud E, Chomienne C, Link H, et al. Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group. Blood 1993; 82: 3241–3249
   PubMed Web of Science ®Google Scholar
• Hughes W T, Armstrong D, Bodey G P, Brown A E, Edwards J E, Feld R, et al. From the Infectious Diseases Society of America guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. J Infec Dis 1990; 161: 381–396
   PubMed Web of Science ®Google Scholar
• Cheson B D, Cassileth P A, Head D R, Schiffer C A, Bennett J M, Bloomfield C D, et al. Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J Clin Oncol 1990; 8: 813–819
   PubMed Web of Science ®Google Scholar
• Byar D P. Identification of prognostic factors. Cancer clinical trials: methods and practice, M E Buyse, M J Staquet, R J Sylvester. Oxford University Press, Oxford 1988; 423–443
   Google Scholar
• Frassoni F, Labopin M, Powles R, Mary J Y, Arcese W, Bacigalupo A, et al. Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation. Lancet 2000; 355: 1393–1398
   PubMed Web of Science ®Google Scholar
• Douer D, Preston-Martin S, Chang E, Nichols P W, Watkins K J, Levine A M. High frequency of acute promyelocytic leukemia among Latinos with acute myeloid leukemia. Blood 1996; 87: 308–313
   PubMed Web of Science ®Google Scholar
• Rego M FN, Pinheiro G S, Metze K, Lorand-Metze I. Acute leukemias in Piauí: comparison with features observed in other regions of Brazil. Braz J Med Biol Res 2003; 36: 331–337
   PubMed Web of Science ®Google Scholar